Equities
Health CareMedical Equipment and Services
  • Price (USD)357.77
  • Today's Change13.06 / 3.79%
  • Shares traded8.00
  • 1 Year change+37.11%
  • Beta0.9814
Data delayed at least 15 minutes, as of Nov 21 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy2
Outperform1
Hold17
Sell1
Strong Sell0

Share price forecast in USD

The 17 analysts offering 12 month price targets for Waters Corp have a median target of 380.00, with a high estimate of 415.00 and a low estimate of 325.00. The median estimate represents a 6.21% increase from the last price of 357.77.
High16.0%415.00
Med6.2%380.00
Low-9.2%325.00

Earnings history & estimates in USD

On Nov 01, 2024, Waters Corp reported 3rd quarter 2024 earnings of 2.93 per share. This result exceeded the 2.68 consensus of the 18 analysts covering the company and exceeded last year's 3rd quarter results by 3.17%.
The next earnings announcement is expected on Feb 04, 2025.
Average growth rate+4.73%
Waters Corp reported annual 2023 earnings of 11.75 per share on Feb 06, 2024.
Average growth rate+7.37%
More ▼

Revenue history & estimates in USD

Waters Corporation had 3rd quarter 2024 revenues of 740.31m. This bettered the 713.02m consensus of the 17 analysts covering the company. This was 8.13% above the prior year's 3rd quarter results.
Average growth rate+2.15%
Waters Corporation had revenues for the full year 2023 of 2.96bn. This was 0.52% below the prior year's results.
Average growth rate+5.56%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.